Biofrontera Inc. Files 8-K on Financials
Ticker: BFRIW · Form: 8-K · Filed: Mar 21, 2025 · CIK: 1858685
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
Related Tickers: BFRI
TL;DR
Biofrontera Inc. (BFRI) filed an 8-K on March 21, 2025, updating its financial condition and results of operations.
AI Summary
Biofrontera Inc. filed an 8-K report on March 21, 2025, detailing its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Woburn, Massachusetts.
Why It Matters
This filing provides an update on Biofrontera Inc.'s financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Biofrontera Inc. (company) — Registrant
- March 21, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- Woburn, Massachusetts (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Biofrontera Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was this 8-K report filed?
This 8-K report was filed on March 21, 2025.
Where are Biofrontera Inc.'s principal executive offices located?
Biofrontera Inc.'s principal executive offices are located at 120 Presidential Way, Suite 330, Woburn, Massachusetts, 01801.
In which state is Biofrontera Inc. incorporated?
Biofrontera Inc. is incorporated in Delaware.
What is the Commission File Number for Biofrontera Inc.'s 8-K filing?
The Commission File Number for Biofrontera Inc.'s 8-K filing is 001-40943.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding Biofrontera Inc. (BFRIW).